Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study
- PMID: 3126927
- PMCID: PMC2545243
- DOI: 10.1136/bmj.296.6622.612
Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study
Abstract
A 10 year study of whooping cough in a discrete general practice community was performed to assess longitudinally the efficacy of pertussis vaccine from one to seven years after immunisation. Of the 436 cases of whooping cough over 10 years, 326 occurred in children aged 1-7 years. The rate of immunisation was known for each cohort of children born during each year, and the attack rate of whooping cough was thus calculated for those immunised and unimmunized. The attack rates were highest in those cohorts exposed to the epidemics of 1977-9, 1981-3, and 1985-7. The efficacy of the vaccine was calculated as a percentage as (attack rate in unimmunized group--attack rate in immunised group) x 100/attack rate in unimmunized group. It fell from 100% in the first year to 46% in the seventh, being 84% in the fourth and only 52% in the fifth. Thus the pertussis vaccine or its schedule of use does not seem to provide sufficient herd immunity to prevent outbreaks of whooping cough. Matters might be improved if vaccination against pertussis were included in the preschool immunisation programme.
Similar articles
-
Whooping cough and pertussis vaccine: a comparison of risks and benefits in Britain during the period 1968-83.Dev Biol Stand. 1985;61:395-405. Dev Biol Stand. 1985. PMID: 3835080
-
An outbreak of whooping cough in a highly vaccinated urban community.J Trop Pediatr. 1991 Mar;37(2):71-6. doi: 10.1093/tropej/37.2.71. J Trop Pediatr. 1991. PMID: 2027168
-
Protection against pertussis by immunisation.Br Med J. 1980 Nov 22;281(6252):1390-1. doi: 10.1136/bmj.281.6252.1390. Br Med J. 1980. PMID: 7437805 Free PMC article.
-
Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy.Vaccine. 2010 Jul 19;28(32):5147-52. doi: 10.1016/j.vaccine.2010.05.070. Epub 2010 Jun 9. Vaccine. 2010. PMID: 20541009 Review.
-
Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review.Euro Surveill. 2013 Sep 19;18(38):20587. doi: 10.2807/1560-7917.es2013.18.38.20587. Euro Surveill. 2013. PMID: 24084340 Review.
Cited by
-
Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.Infect Immun. 1999 Oct;67(10):5100-5. doi: 10.1128/IAI.67.10.5100-5105.1999. Infect Immun. 1999. PMID: 10496883 Free PMC article.
-
Recommendation for the use of newly introduced Tdap vaccine in Korea.Korean J Pediatr. 2011 Apr;54(4):141-5. doi: 10.3345/kjp.2011.54.4.141. Epub 2011 Apr 30. Korean J Pediatr. 2011. PMID: 21738546 Free PMC article.
-
Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions.Expert Rev Vaccines. 2024 Jan-Dec;23(1):705-714. doi: 10.1080/14760584.2024.2383745. Epub 2024 Jul 24. Expert Rev Vaccines. 2024. PMID: 39037200 Free PMC article. Review.
-
The situation of vaccines for the prevention of infections in adults: An opinion paper on the situation in Spain.Rev Esp Quimioter. 2019 Aug;32(4):333-364. Epub 2019 Jul 26. Rev Esp Quimioter. 2019. PMID: 31345005 Free PMC article.
-
Pertussis: Microbiology, Disease, Treatment, and Prevention.Clin Microbiol Rev. 2016 Jul;29(3):449-86. doi: 10.1128/CMR.00083-15. Clin Microbiol Rev. 2016. PMID: 27029594 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical